Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time
Version 2 2024-06-05, 11:22
Version 1 2017-03-01, 00:00
journal contribution
posted on 2024-06-05, 11:22 authored by A Heald, M Livingston, Alison YungAlison Yung, MA De HertPrescribing in schizophrenia and psychosis: Increasing polypharmacy over time
History
Related Materials
- 1.
Location
EnglandLanguage
EnglishPublication classification
C1 Refereed article in a scholarly journalJournal
Human PsychopharmacologyVolume
32Article number
ARTN e2579Pagination
1 - 4ISSN
0885-6222eISSN
1099-1077Issue
2Publisher
WILEYUsage metrics
Categories
Keywords
Science & TechnologySocial SciencesLife Sciences & BiomedicineClinical NeurologyPharmacology & PharmacyPsychiatryPsychologyNeurosciences & NeurologyBMIprescribingpsychosispsychotropicschizophreniaBODY-MASS INDEXMENTAL-ILLNESSANTIPSYCHOTICSCLOZAPINEWEIGHTPEOPLE3214 Pharmacology and pharmaceutical sciences3202 Clinical sciences3209 Neurosciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC